Sorrento Therapeutics’ Antibody Treatment May Kill Coronavirus, Can Open Society Without Fear

Sorrento Therapeutics’ Antibody Treatment May Kill Coronavirus, Can Open Society Without Fear

$SRNE

Sorrento Therapeutics (NASDAQ:SRNE), a Southern California-based biopharmaceutical company, says it may have found a way to eradicate the C-19 coronavirus. 

Sorrento announced it has found an antibody that could protect the body from the coronavirus and eliminate it from a person within 4 days

The company formally announced its discovery of the STI-1499 antibody, which they say can provide “100% inhibition” of C-19 coronavirus Friday.

Sorrento officials say its treatment could be available months before a vaccine is ready. 

We want to emphasize there is a cure. There is a solution that works 100%,” the company’s founder and CEO Dr. Henry Ji told said on TV. “If we have the neutralizing antibody in your body, you do not need the social distancing. You can open up a society without fear.”

When the antibody prevents a virus from entering a human cell, the virus cannot survive,” Dr. Ji said. “If they cannot get into the cell, they cannot replicate. So it means that if we prevent the virus from getting the cell, the virus eventually dies out. The body clears out that virus.

Dr. Ji said the antibody can be used as a preventative treatment because there are no side effects. He said it may be more effective than a vaccine. 

This is the best solution,” he said. “The point of making a vaccine is to generalize a neutralizing antibody. So, if you already have one, you don’t need to the body to generate one from a vaccine. You have already provided it. You’re cutting out the middleman.”

The company is developing the antibody as a therapy for C-19 coronavirus.

Sorrento said it can provide up to 200,000 doses per month and is looking to produce tens of millions more to meet projected demands.

“As soon as it is infused, that patient is now immune to the disease,” SVP of Sorrento Dr. Mark Brunswick said. “For the length of time, the antibody is in that system. So, if we were approved by the FDA today, everyone who gets that antibody can go back to work and have no fear of catching COVID-19.”

SRNE finished Friday at 6.76, +4.14 after marking a high at 9.0

There is Key Support at 5.08 and the Resistance is NIL

HeffX-LTN’s overall technical analysis is Bullish across the board.

Have a healthy weekend, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.